Skip to main content
Premium Trial:

Request an Annual Quote

Synergy Oncology to Develop Tumor Profiling Test Using Sophia Genetics DDM Platform

NEW YORK – Sophia Genetics said Tuesday that the Synergy Oncology division of Synergy Laboratories will incorporate the Sophia DDM analytics platform into a new tumor profiling test.

Mobile, Alabama-based Synergy Oncology plans to launch Totality, which will sequence genes from solid tumors and use the hereditary cancers module in Sophia DDM to analyze the data in order to provide physicians with reports to match variants with Food and Drug Administration-approved therapies as well as ongoing clinical trials. Sophia, which has twin headquarters in Saint-Sulpice, Switzerland, and Boston, said that this will give Synergy a "one-stop solution" as the molecular diagnostics firm expands into new oncology areas.

In a statement, Ken Freedman, chief revenue officer of Sophia, called this collaboration "an important step in creating cancer profiling solutions that will progress research and treatments of hereditary cancers for the medical community."

Joseph Cohil, head of Synergy Oncology, added that the deal "will accelerate Synergy's leading hereditary cancer technology to the forefront of patient outcomes."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.